Clinical Trial Update: The 36-month Extension to Follow up Sub Study

View source ↗

Summary

The 36-month extension to the follow-up sub-study of trial NCT01615692 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Post-thrombotic Syndrome

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Postphlebitic Syndrome, Post-Thrombotic Syndrome | Status: WITHDRAWN